Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor 4 hours ago
MarketsTrading IdeasPre-Market OutlookNewsAnalyst RatingsPrice Target
Analysts upgraded MHK and CRWD, downgraded PFSI, cut ABOS’s target, and raised targets for NRXP, REGN and NTSK.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- BTIG cut the price target for Acumen Pharmaceuticals Inc (NASDAQ:ABOS) from $8 to $1. BTIG analyst Thomas Shrader maintained a Buy rating. Acumen Pharmaceuticals shares closed at $0.21 on Friday. See how other analysts view this stock.
- Keefe, Bruyette & Woods slashed PennyMac Financial Services Inc (NYSE:PFSI) price target from $100 to $80. Keefe, Bruyette & Woods analyst George Bose downgraded the stock from Outperform to Market Perform. PennyMac Financial shares closed at $62.92 on Friday. See how other analysts view this stock.
- Ascendiant Capital raised price target for NRX Pharmaceuticals Inc (NASDAQ:NRXP) from $50 to $51. Ascendiant Capital analyst Edward Woo maintained a Buy rating. NRX Pharmaceuticals shares closed at $2.27 on Friday. See how other analysts view this stock.
- B of A Securities boosted the price target for Regeneron Pharmaceuticals Inc (NASDAQ:REGN) from $908 to $1,030. B of A Securities analyst Tazeen Ahmad maintained a Buy rating. Regeneron Pharmaceuticals shares closed at $927.89 on Friday. See how other analysts view this stock.
- Evercore ISI Group raised Mohawk Industries Inc (NYSE:MHK) price target from $129 to $171. Evercore ISI Group analyst Stephen Kim upgraded the stock from In-Line to Outperform. Mohawk Industries shares closed at $139.41 on Friday. See how other analysts view this stock.
- Deutsche Bank increased Crowdstrike Holdings Inc (NASDAQ:CRWD) price target from $240 to $300. Deutsche Bank analyst Brad Zelnick upgraded the stock from Hold to Buy. Crowdstrike shares closed at $250.43 on Friday. See how other analysts view this stock.
- BTIG raised Netskope Inc (NASDAQ:NTSK) price target from $22 to $30. BTIG analyst Gray Powell maintained a Buy rating. Netskope shares closed at $24.30 on Friday. See how other analysts view this stock.
- Morgan Stanley cut the price target for Coinbase Global Inc (NASDAQ:COIN) from $258 to $120. Morgan Stanley analyst Michael Cyprys downgraded the stock from Equal-Weight to Underweight. Coinbase shares closed at $143.54 on Friday. See how other analysts view this stock.
- Baird raised Hyatt Hotels Corporation (NYSE:H) price target from $188 to $194. Baird analyst Michael Bellisario maintained a Neutral rating. Hyatt shares closed at $180.57 on Friday. See how other analysts view this stock.
- HC Wainwright & Co. raised Biogen Inc (NASDAQ:BIIB) price target from $251 to $270. HC Wainwright & Co. analyst Ananda Ghosh maintained a Buy rating. Biogen shares closed at $253.62 on Friday. See how other analysts view this stock.
Considering buying REGN stock? Here’s what analysts think:

Photo via Shutterstock